Clinical trial

Strontium Compared With Radiation Therapy in Treating Patients With…

NCT00002503 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed

Key facts

NCT number NCT00002503
Title Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases
Official title A PROSPECTIVE MULTICENTER RANDOMIZED STUDY COMPARING STRONTIUM-89 CHLORIDE AND PALLIATIVE LOCAL FIELD RADIOTHERAPY IN PATIENTS WITH HORMONAL ESCAPED ADVANCED PROSTATIC CANCER
Lead sponsor European Organisation for Research and Treatment of Cancer - EORTC, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Metastatic Cancer, Prostate Cancer
Intervention type Radiation
Interventions strontium chloride Sr 89
Enrollment 204
Start date Oct 1, 1992
Primary completion Nov 1, 2000
First posted May 20, 2004
Last update posted Sep 24, 2012
Countries Belgium, Denmark, Italy, Netherlands, Poland, Portugal, Russia, Switzerland, United Kingdom

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies